Mixed cryoglobulinaemic vasculitis (MCV) is an immune-complex-mediated systemic vasculitis characterised by heterogeneous clinical manifestations mainly involving lymphatic system, skin, kidney and peripheral nervous system. Although MCV patients have been included in priority programs for vaccination against SARS-CoV-2 in Italy, limited information is available for these patients. Aims of this multicentre Italian study were to investigate SARS-CoV-2 vaccination rate in MCV patients and its safety profile.

COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis / Vacchi, Caterina; Testoni, Sofia; Visentini, Marcella; Zani, Roberta; Lauletta, Gianfranco; Gragnani, Laura; Filippini, Davide; Mazzaro, Cesare; Fraticelli, Paolo; Quartuccio, Luca; Padoan, Roberto; Castelnovo, Laura; Zignego, Anna Linda; Ferri, Clodoveo; Scarpato, Salvatore; Casato, Milvia; Hoxha, Ariela; Salvarani, Carlo; Monti, Giuseppe; Galli, Massimo; Sebastiani, Marco. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - (2022), pp. 1-1. [10.55563/clinexprheumatol/ldv88a]

COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis

Vacchi, Caterina;Testoni, Sofia;Ferri, Clodoveo;Salvarani, Carlo;Sebastiani, Marco
2022

Abstract

Mixed cryoglobulinaemic vasculitis (MCV) is an immune-complex-mediated systemic vasculitis characterised by heterogeneous clinical manifestations mainly involving lymphatic system, skin, kidney and peripheral nervous system. Although MCV patients have been included in priority programs for vaccination against SARS-CoV-2 in Italy, limited information is available for these patients. Aims of this multicentre Italian study were to investigate SARS-CoV-2 vaccination rate in MCV patients and its safety profile.
1
1
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis / Vacchi, Caterina; Testoni, Sofia; Visentini, Marcella; Zani, Roberta; Lauletta, Gianfranco; Gragnani, Laura; Filippini, Davide; Mazzaro, Cesare; Fraticelli, Paolo; Quartuccio, Luca; Padoan, Roberto; Castelnovo, Laura; Zignego, Anna Linda; Ferri, Clodoveo; Scarpato, Salvatore; Casato, Milvia; Hoxha, Ariela; Salvarani, Carlo; Monti, Giuseppe; Galli, Massimo; Sebastiani, Marco. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - (2022), pp. 1-1. [10.55563/clinexprheumatol/ldv88a]
Vacchi, Caterina; Testoni, Sofia; Visentini, Marcella; Zani, Roberta; Lauletta, Gianfranco; Gragnani, Laura; Filippini, Davide; Mazzaro, Cesare; Fraticelli, Paolo; Quartuccio, Luca; Padoan, Roberto; Castelnovo, Laura; Zignego, Anna Linda; Ferri, Clodoveo; Scarpato, Salvatore; Casato, Milvia; Hoxha, Ariela; Salvarani, Carlo; Monti, Giuseppe; Galli, Massimo; Sebastiani, Marco
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1284444
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact